Isoray, Inc (NYSE: ISR)
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Isoray, Inc (“the Company”) (NYSE: ISR) with Viewpoint Molecular Targeting, Inc. pursuant to which Viewpoint shareholders will end up owning 49% of the fully diluted outstanding capital stock of Isoray. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company’s shareholders.
If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (firstname.lastname@example.org) toll free at any time at 855-768-1857, or fill out the form on this page.